OXALIPLATINA 50 MG PO LIOF P/ SOL INJ IV CT FA VD AMB X 50 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1101302370013
  • GGREM 521903702155114
  • Código de barras 7897473202061

O que a fonte publica

Detentor do registro
GLENMARK FARMACÊUTICA LTDA
Princípios ativos
OXALIPLATINA
Embalagem
50 MG PO LIOF P/ SOL INJ IV CT FA VD AMB X 50 ML
Tipo de produto
Genérico
Classe terapêutica
L1F - COMPOSTOS ANTINEOPLÁSICOS DE PLATINA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:521903702155114
{
  "name": "OXALIPLATINA 50 MG PO LIOF P/ SOL INJ IV CT FA VD AMB X 50 ML",
  "holder": "GLENMARK FARMACÊUTICA LTDA",
  "stripe": null,
  "barcodes": [
    "7897473202061"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "521903702155114",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "44.363.661/0001-57",
  "priceRegime": "Regulado",
  "productName": "OXALIPLATINA",
  "productType": "Genérico",
  "hospitalOnly": true,
  "presentation": "50 MG PO LIOF P/ SOL INJ IV CT FA VD AMB X 50 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "1513.33",
    "icms-12": "1719.69",
    "icms-17": "1823.29",
    "icms-18": "1845.52",
    "icms-19": "1868.31",
    "icms-20": "1891.66",
    "icms-21": "1915.61",
    "icms-22": "1940.17",
    "icms-23": "1965.36",
    "icms-17.5": "1834.34",
    "icms-19.5": "1879.91",
    "icms-20.5": "1903.56",
    "icms-22.5": "1952.68",
    "icms-12-alc": "1699.06",
    "icms-17-alc": "1801.41",
    "icms-18-alc": "1823.38",
    "icms-19-alc": "1845.89",
    "icms-20-alc": "1868.96",
    "icms-21-alc": "1892.62",
    "icms-22-alc": "1916.88",
    "icms-23-alc": "1941.78",
    "withoutTaxes": "1495.17",
    "icms-17.5-alc": "1812.33",
    "icms-19.5-alc": "1857.35",
    "icms-20.5-alc": "1880.72",
    "icms-22.5-alc": "1929.25"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "OXALIPLATINA",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "OXALIPLATINA"
  ],
  "therapeuticClass": "L1F - COMPOSTOS ANTINEOPLÁSICOS DE PLATINA",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1101302370013",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L1F",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:521903702155114"